Expense management software provider Fenbeitong has closed a series B-plus round co-led by Fidelity’s Eight Roads firm, pushing its total funding to more than $58m.
Month: March 2020
Corporates help invest $13m in The Recount
ViacomCBS and Burda Principal Investments took part in a series A round for the political media startup that was led by Union Square Ventures.
Axa accelerates Cognism’s series B to $22m
Axa Venture Partners led the $12m second close of a $22m round for AI-equipped sales intelligence platform developer Cognism.
Nissan mulls Alliance Ventures withdrawal
Mitsubishi has reportedly elected to stop providing funding for the $1bn CVC partnership and Nissan to possibly follow.
George Health gees up to raise $35m
George Health Enterprises and its subsidiary George Medicines have raised a combined $35m in funding from investors including Bupa Australia to drive pipeline development and commercialisation.
TSI Holdings lends help for Lyra’s second fund
Fashion conglomerate TSI Holdings has backed a fund of undisclosed size launched by fashion tech-focused venture capital firm Lyra Ventures.
Nothing magic in Europe’s mushrooming venture ecosystem
Bristol Myers Squibb and Otsuka Pharmaceutical committing to LSP’s $600m life sciences fund is a further sign of the integration between strategic and financial investors.
Corporates help LSP clasp $600m for new fund
Bristol Myers Squibb and Otsuka Pharmaceutical were among the limited partners for what LSP said is Europe’s largest ever life sciences VC fund.
Enagás energises $170m joint venture fund
The Spain-based energy utility is set to contribute approximately $23m to the vehicle, which will invest in renewable energy technology developers.
Everlaw runs the rule on $62m round
CapitalG co-led a series C round for Everlaw, developer of a legal information search product, which has now secured more than $96m in total.
Silverback racks up series B funding
Bristol-Meyers Squibb participated in the $78.5m round, which will be used to push Silverback Therapeutics’ lead cancer drug candidate towards clinical trials.
Zumper pumps in another $60m
The Marcus & Millichap and Axel Springer-backed rental real estate portal has completed its series D round to bring its overall equity funding to more than $150m.
Lightbend twists $25m out of investors
Juniper Networks, Intel and IBM returned for a round led by Dell Technologies Capital that took the application development platform’s total funding to $77m.
Numab makes room for series B funding
The cancer immunotherapy developer has closed a $23.6m round featuring 3SBio Group and Eisai, both of which have signed collaboration agreements with it in recent months.